Evidence map›Paper›PMID 20231139›Full record

ArticleThe Journal of physiology2010

Substance P inhibits GABAB receptor signalling in the ventral tegmental area.

Yan-Fang Xia, Elyssa B Margolis, Gregory O Hjelmstad

Open access · greenAbstract read
In one paragraph

Article in The Journal of physiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Nicotine enhances excitability of medial habenular neurons via facilitation of neurokinin signaling.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2014
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yan-Fang XiaErnest Gallo Clinic and Research Center, 5858 Horton Street, Suite 200, Emeryville, CA 94608, USA.
Elyssa B Margolis
Gregory O Hjelmstad
Ernest Gallo Clinic and Research Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Substance P (SP) and its receptors are involved in anxiety-related behaviours and regulate the intake of drugs of abuse and alcohol. Within the midbrain ventral tegmental area (VTA), a region that is clearly involved in the control of these behaviours, SP is released by stress and has been shown to trigger relapse. SP activates neurokinin (NK) receptors, which excites midbrain dopamine (DA) neurons and leads to increased DA in target regions. In this study, we have investigated the mechanisms underlying SP actions in the VTA, specifically investigating interactions between SP and GABA(B) receptors. We show that in VTA neurons, NK receptor activation closes an inwardly rectifying potassium channel, and moreover inhibits GABA(B) receptor-mediated transmission through an interaction that depends upon phospholipase C (PLC), intracellular calcium and protein kinase C (PKC).

Indexed as

GABA AntagonistsGABA-B Receptor AntagonistsAnimalsBaclofenChelating AgentsDopamineEgtazic AcidElectrophysiologyGABA AgonistsG Protein-Coupled Inwardly-Rectifying Potassium ChannelsImmunohistochemistryIn Vitro TechniquesMaleMembrane PotentialsPatch-Clamp TechniquesProtein Kinase C1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acidBaclofenChelating AgentsDopamineEgtazic AcidGABA AgonistsGABA AntagonistsGABA-B Receptor AntagonistsG Protein-Coupled Inwardly-Rectifying Potassium ChannelsProtein Kinase CReceptors, Neurokinin-1Receptors, Neurokinin-2Substance PTyrosine 3-Monooxygenase

Identifiers

PMID20231139
PMCPMC2876808
OpenAlexW2117719486

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.